All cancer types, Secondary cancers
Results
Phase 3
This trial looked at methylphenidate for moderate to severe tiredness (fatigue). It was for people with .
People could join the trial between 2018 and 2023. The team published the results in 2024.
Recruitment start: 29 June 2018
Recruitment end: 27 April 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Patrick Stone
Marie Curie Cancer Care
National Institute for Health and Care Research
NIHR Health Technology Assessment (HTA) programme
Priment Clinical Trial Unit
University College London (UCL)
Last reviewed: 12 Jun 2026
CRUK internal database number: 15240